P
ORIC icon

Pfizer’s Oric Pharmaceuticals ORIC Stock Holding History

Pfizer’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Sell
372,904
-4,407,497
-92% -$40M 2.09% 10
2026
Q1 		$57.7M Sell
4,780,401
-595,943
-11% -$6.77M 24.14% 1
2025
Q4 		$44M Hold
5,376,344
– – 18.6% 1
2025
Q3 		$64.5M Hold
5,376,344
– – 14.75% 2
2025
Q2 		$54.6M Hold
5,376,344
– – 9.47% 2
2025
Q1 		$30M Hold
5,376,344
– – 5.99% 3
2024
Q4 		$43.4M Buy
+5,376,344
New +$49.3M 1.67% 5

Other funds holding ORIC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pfizer's ORIC Position: Q2 2026 in Review

Pfizer reduced its Oric Pharmaceuticals (ORIC) stake by 92% in Q2 2026, selling an estimated $40M and leaving 372,904 shares worth $3.55M. The position accounts for 2.09% of the portfolio, ranked #10.

Pfizer first reported a position in ORIC in Q4 2024 and has held it in 7 quarters since. The position peaked at $64.5M in Q3 2025. 100 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Pfizer held 372,904 shares of Oric Pharmaceuticals worth $3.55M as of Q2 2026.
  • Pfizer sold 4,407,497 Oric Pharmaceuticals shares in Q2 2026, an estimated $40M.
  • Oric Pharmaceuticals made up 2.09% of Pfizer's portfolio in Q2 2026, its #10 holding.
  • Pfizer first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Pfizer's Oric Pharmaceuticals position peaked at $64.5M in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.